IOL CHEMICALS AND PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of IOL CHEMICALS AND PHARMACEUTICALS have increased by 1.52% YoY .
The Earnings Per Share (EPS) of IOL CHEMICALS AND PHARMACEUTICALS has decreased by -3.38 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
IOL CHEMICALS AND PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524164|NSE : IOLCP]
| Consolidated | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|
| Revenues | ₹2,217 Cr | ₹2,184 Cr | ₹2,184 Cr |
| Expenses | ₹1,991 Cr | ₹1,926 Cr | ₹1,926 Cr |
| Operating Profit (Excl OI) | ₹226 Cr | ₹258 Cr | ₹258 Cr |
| Other Income | ₹26 Cr | ₹32 Cr | ₹32 Cr |
| Interest | ₹16 Cr | ₹8.29 Cr | ₹8.29 Cr |
| Depreciation | ₹46 Cr | ₹43 Cr | ₹43 Cr |
| Profit Before Tax | ₹189 Cr | ₹225 Cr | ₹225 Cr |
| Profit After Tax | ₹139 Cr | ₹168 Cr | ₹168 Cr |
| Consolidated Net Profit | ₹139 Cr | ₹168 Cr | ₹168 Cr |
| Earnings Per Share (Rs) | ₹22.90 | ₹23.70 | ₹28.56 |
| PAT Margin (%) | 6.30 | 6.28 | 7.68 |
| ROE(%) | 8.62 | 9.60 | 12.04 |
| ROCE(%) | 12.24 | 13.57 | 16.25 |
| Total Debt/Equity(x) | 0.02 | 0.05 | 0.03 |
Key Financials |
||
| Market Cap | : | ₹ 2,222.7 Cr |
| Revenue (TTM) | : | ₹ 2,052.4 Cr |
| Net Profit(TTM) | : | ₹ 99.8 Cr |
| EPS (TTM) | : | ₹ 17.0 |
| P/E (TTM) | : | 22.3 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| IOL CHEMICALS AND PHARMACEUTICALS | -12.5% | -9.3% | -12.9% |
| SUN PHARMACEUTICAL INDUSTRIES | -5.8% | -3.2% | 35.1% |
| CIPLA | -3.9% | -0.5% | 13.9% |
| DR REDDYS LABORATORIES | -1.2% | 7.1% | 17.8% |
| ZYDUS LIFESCIENCES | -2.7% | -0.1% | 40.9% |
| DIVIS LABORATORIES | -2.8% | -3.6% | 44.7% |
| MANKIND PHARMA | -11.2% | -2.3% | 33.6% |
| TORRENT PHARMACEUTICALS | -4.8% | -2.7% | 40.1% |
| LUPIN | -8.6% | 1.8% | 56.9% |
IOL CHEMICALS AND PHARMACEUTICALS Revenues
[BOM: 524164|NSE : IOLCP]
| Y-o-Y | 1.52 % |
| 5 Yr CAGR | 0.75 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹2,217 Cr | 1.52 | |
| Mar2023 | ₹2,184 Cr | 0.00 | |
| Mar2022 | ₹2,184 Cr | - | |
IOL CHEMICALS AND PHARMACEUTICALS Operating Profit
[BOM: 524164|NSE : IOLCP]
| Y-o-Y | -12.63 % |
| 5 Yr CAGR | -6.53 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹226 Cr | -12.63 | |
| Mar2023 | ₹258 Cr | 0.00 | |
| Mar2022 | ₹258 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -13.95 % |
| 5 Yr CAGR | -7.24 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 10.18% | -13.95 | |
| Mar2023 | 11.83% | 0.00 | |
| Mar2022 | 11.83% | - | |
IOL CHEMICALS AND PHARMACEUTICALS Profit After Tax
[BOM: 524164|NSE : IOLCP]
| Y-o-Y | -17.02 % |
| 5 Yr CAGR | -8.90 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹139 Cr | -17.02 | |
| Mar2023 | ₹168 Cr | 0.00 | |
| Mar2022 | ₹168 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.32 % |
| 5 Yr CAGR | -9.43 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 6.3 % | 0.32 | |
| Mar2023 | 6.28 % | -18.23 | |
| Mar2022 | 7.68 % | - | |
IOL CHEMICALS AND PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524164|NSE : IOLCP]
| Y-o-Y | -3.38 % |
| 5 Yr CAGR | -10.46 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹23 | -3.38 | |
| Mar2023 | ₹24 | -17.02 | |
| Mar2022 | ₹29 | - | |
IOL CHEMICALS AND PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524164|NSE : IOLCP]
| Y-o-Y | -9.80 % |
| 5 Yr CAGR | -13.21 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 12.24% | -9.80 | |
| Mar2023 | 13.57% | -16.49 | |
| Mar2022 | 16.25% | - | |
IOL CHEMICALS AND PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹378.7 |
| Current MarketCap | : | ₹ 2,222.7 Cr |
| Updated EOD on | : | Jan 13,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IOL CHEMICALS AND PHARMACEUTICALS | -12.5% |
-9.3% |
-12.9% |
| SENSEX | -2.1% |
-6.4% |
7% |
IOL CHEMICALS AND PHARMACEUTICALS related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| S&P BSE ALLCAP | -0.3% | -3.5% | 35.8% |
| S&P BSE HEALTHCARE | -5.3% | -4.2% | 32% |
| S&P BSE SMALL CAP | -7% | -12.4% | 15.8% |
| S&P BSE MIDSMALLCAP | -7.2% | -12.1% | 14.7% |
No NSE index found
You may also like the below Video Courses
FAQ about IOL CHEMICALS AND PHARMACEUTICALS Financials
How the annual revenues of IOL CHEMICALS AND PHARMACEUTICALS have changed ?
The Revenues of IOL CHEMICALS AND PHARMACEUTICALS have increased by 1.52% YoY .
How the Earnings per Share (EPS) of IOL CHEMICALS AND PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of IOL CHEMICALS AND PHARMACEUTICALS has decreased by -3.38 % YoY .
Check out Intrinsic Value of Peers of IOL CHEMICALS AND PHARMACEUTICALS
Compare Stock Analytics of Peers of IOL CHEMICALS AND PHARMACEUTICALS
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
